Please ensure Javascript is enabled for purposes of website accessibility

Notice of 2024 Annual Meeting of Stockholders and Proxy Statement

Notice of 2024 Annual Meeting of Stockholders and Proxy Statement

Meeting Information

Date and Time

Thursday, May 16, 2024 at 8:00 A.M., Eastern Time

Download calendar invite

  • Link will be “live” beginning at 7:45 A.M., Eastern Time on May 16, 2024.
  • To be admitted to the Annual Meeting, enter the 16-digit control number found on proxy card, Notice of Availability or voter instruction form, as applicable.
  • If you experience technical difficulties, please call Broadridge (the Annual Meeting website host) at 844-986-0822 (US) or 303-562-9302 (International).

Items of Business

Item 1

Election of directors
  • Our 12 continuing directors are seasoned leaders who bring a mix of skills and qualifications to our Board of Directors
FOR each director nominee

Item 2

Ratify the appointment of the Company’s independent registered public accounting firm for 2024
  • Based on its recent evaluation, our Audit Committee believes that the retention of Ernst & Young LLP is in the best interests of the Company and its stockholders

Item 3

Say on pay - an advisory vote on the approval of the Company’s executive compensation
  • Our executive compensation program reflects our unwavering commitment to paying for performance and reflects feedback received from stockholder outreach

Item 4

Adopt amendments to the Company’s 2017 Incentive Compensation Plan (the “2017 ICP”)
  • The amendments to our 2017 ICP will replenish the shares available under the plan and replace two recently acquired existing equity compensation plans; it will be an important tool to attract and retain quality executives and employees

Items 5-8

Stockholder proposals

  • See the Board of Directors’ statement of opposition AGAINST each stockholder proposal




Follow Us

© 2024 CVS Health Corporation